We are excited to announce that e6data has successfully raised $10 million in its latest funding round, which marks a significant milestone for the company as we continue to innovate in the data management space. Designed to cater specifically to the relentless demands of the 10% of heavy use-cases that consume 80% of resources, e6data reforms the landscape of data processing by delivering solutions that are five times faster and come with a 50% lower total cost of ownership (TCO) compared to traditional options. With this new capital, we aim to enhance our existing platform, reinforcing our commitment to enabling organizations to escape the constraints of ecosystem lock-in—be it through lakehouse formats, catalogs, or governance measures. Our unique model promotes zero friction adoption, ensuring that businesses can seamlessly transition to our services without the burden of data movement, application changes, or any downtime. This funding will be instrumental in expanding our engineering team and accelerating product development, allowing us to continue providing unmatched performance and efficiency to our clients. We are thrilled to embark on this journey, advocating for a solution that not only maximizes operational efficiency but also empowers organizations to truly leverage their data resources without constraints. Thank you to our investors for believing in our vision; together, we are poised to transform the data landscape and redefine how enterprises operate in an increasingly data-driven world.

Revolutionizing Data Management: e6data Secures $10M in Series A Funding for Breakthrough Solutions
Get the full e6data company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
BioStem Technologies
BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.
$2.5M Unknown
today

Edify Systems
When you're running 10+ stores, the cracks in your operations become expensive. Inconsistent stock levels across sites, manual processes that don't scale, food waste that eats into margins, and zero real time visibility for the ops team. That's what Edify solves. Our AI powered platform gives operations leaders a single system to manage inventory, plan production, and report across their entire estate, whether that's 20 locations or 500. Built in intelligence surfaces the insights that matter, so your team spends less time in spreadsheets and more time running operations. What we cover: Inventory management across all sites. AI driven production planning and prep workflows. Operational reporting and real time visibility. Multi location scalability built in from day one. We work with QSR brands and multi site coffee chains who have outgrown spreadsheets and fragmented systems but need something purpose built for high volume, multi unit operations. If your back of house is holding back your growth, we should talk.
$4.0M Seed
today

Generalist
Generalist is an AI robotics company building general intelligence for the physical world. The founding team includes engineers from OpenAI, Google DeepMind, and Boston Dynamics. The company embraces both large-scale AI and robotics as core to its DNA.
$400.0M Unknown
today

Scotch
From neighborhood stores to destination warehouses, liquor retailers of all sizes have been held back by manual tasks, slow systems and limited business intelligence. So we decided to build something better — smarter software that saves time and improves margins so independent retailers could focus on their customers, not manually managing inventory.
$20.0M Series a
today

Kempfer / K Creative Office
Based in São Paulo, we specialize in social media creation and content, delivering creative solutions that connect, engage, and inspire Com sede em São Paulo, somos especialistas em criação e conteúdo para social media, entregando soluções criativas que conectam, envolvem e inspiram.
$1.3M Unknown
today
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Scotch United States | Series a | $20.0M | today |
| 2 | ![]() vorteX-io France | Series a | $9.2M | today |
| 3 | ![]() Scispot Canada | Series a | $8.0M | today |
| 4 | ![]() Lassie United States | Series a | $47.0M | today |
| 5 | ![]() Terra AI United States | Series a | $20.0M | today |



